Register | Log in | FAQ      [?] 
Recent | Recommended | Search | Authors | Tags | Export

Group: HEIRS Diabetes, Insulin Resistance and Metabolic Syndrome Research - library [186 articles]

Recent papers posted by members of the HEIRS Diabetes, Insulin Resistance and Metabolic Syndrome Research group
RIS BibTeX RTF/PDF
  • Butein, a Specific Protein Tyrosine Kinase Inhibitor
    Biochemical and Biophysical Research Communications, Vol. 245, No. 2. (17 April 1998), pp. 435-438.
    by E Yang
  • Butein, a more effective antioxidant than α-tocopherol
    Journal of Molecular Structure: THEOCHEM, Vol. 763, No. 1-3. (28 April 2006), pp. 161-164.
    by W Chen, J Song, P Guo, Z Wen
  • Butein, a Tetrahydroxychalcone, Inhibits Nuclear Factor (NF)-kappaB and NF-kappaB-regulated Gene Expression through Direct Inhibition of IkappaBalpha Kinase beta on Cysteine 179 Residue
    J. Biol. Chem., Vol. 282, No. 24. (15 June 2007), pp. 17340-17350.
    by Manoj K Pandey, Santosh K Sandur, Bokyung Sung, Gautam Sethi, Ajaikumar B Kunnumakkara, Bharat B Aggarwal
  • Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    The Journal of pharmacy and pharmacology, Vol. 53, No. 5. (May 2001), pp. 653-668.
    by SS Lim, SH Jung, J Ji, KH Shin, SR Keum
  • Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Asia Pacific journal of clinical nutrition, Vol. 17, No. 4. (2008), pp. 558-565.
  • Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice.
    Nutrition and cancer, Vol. 61, No. 1. (2009), pp. 146-155.
    by B Wang, G Bobe, JJ LaPres, LD Bourquin
  • High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
    Am J Physiol Cell Physiol, Vol. 296, No. 1. (1 January 2009), pp. C182-192.
    by Sumathy Mohan, Ryszard Konopinski, Bo Yan, Victoria E Centonze, Mohan Natarajan
  • Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease
    N Engl J Med (10 December 2008), NEJMoa0807917.
    by Deborah J Smyth, Vincent Plagnol, Neil M Walker, Jason D Cooper, Kate Downes, Jennie H Yang, Joanna M Howson, Helen Stevens, Ross Mcmanus, Cisca Wijmenga, Graham A Heap, Patrick C Dubois, David G Clayton, Karen A Hunt, David A van Heel, John A Todd
  • Combined Use of Rosiglitazone and Fenofibrate in Patients With Type 2 Diabetes
    (20 February 2007)
    by Guenther Boden, Carol Homko, Maria Mozzoli, Meijuan Zhang, Karen Kresge, Peter Cheung
  • PPARgamma-mediated insulin sensitization: the importance of fat versus muscle
    Am J Physiol Endocrinol Metab, Vol. 288, No. 2. (1 February 2005), pp. E287-291.
    by Ulrich Kintscher, Ronald E Law
  • Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
    J. Clin. Invest, Vol. 116, No. 4. (2006), pp. 1071-1080.
    by Xueliang Du, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou, Michael Brownlee
  • HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and independent mechanisms
    Am J Physiol Endocrinol Metab (18 November 2008), 90513.2008.
    by Christy L White, Amy Whittington, Maria J Barnes, Zhong Q Wang, George Bray, Christopher D Morrison
  • Sirt1 protects against high-fat diet-induced metabolic damage.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 28. (15 July 2008), pp. 9793-9798.
  • Phosphorylation of PTP1B at Ser50 by Akt Impairs Its Ability to Dephosphorylate the Insulin Receptor
    Mol Endocrinol, Vol. 15, No. 10. (1 October 2001), pp. 1768-1780.
    by Lingamanaidu V Ravichandran, Hui Chen, Yunhua Li, Michael J Quon
  • A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases
    Recent Patents on Cardiovascular Drug Discovery, Vol. 3 (2008), pp. 156-164.
    by Sivaram Pillarisetti
  • Comparative analysis of tryptophan oxygenase activity and glucocorticoid receptor under the influence of insulin.
    Physiological research / Academia Scientiarum Bohemoslovaca, Vol. 57, No. 1. (2008), pp. 101-107.
  • Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity through suppressing NF-kappaB signaling pathway.
    Diabetes (13 November 2008)
    by Ji-Hyun H Lee, Mi-Young Y Song, Eun-Kyung K Song, Eun-Kyung K Kim, Woo Sung Moon, Myung-Kwan K Han, Jin-Woo W Park, Kang-Beom B Kwon, Byung-Hyun H Park
  • Stress-Induced Hyperglycemia in Patients With Severe Sepsis: A Compromising Factor for Survival
    The American Journal of the Medical Sciences (December 2008), pp. 467-471.
    by Leonidia MD Leonidou, Ageliki MD Leonardou, Eftihia MD Polyzogopoulou, Kalliopi MD Fouka, Miltiadis MD Gerolymos, Pantelis MD Leonardos, Agathoklis MD Psirogiannis, Charalambos A Gogos
  • The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus
    Nutrition & Metabolism, Vol. 5, No. 1. (2008)
    by Eric Westman, William Yancy, John Mavropoulos, Megan Marquart, Jennifer Mcduffie
  • Nutrient control of glucose homeostasis through a complex of PGC-1[alpha] and SIRT1
    Nature, Vol. 434, No. 7029. (03 March 2005), pp. 113-118.
    by Joseph T Rodgers, Carlos Lerin, Wilhelm Haas, Steven P Gygi, Bruce M Spiegelman, Pere Puigserver
  • Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.
    Science, Vol. 303, No. 5666. (26 March 2004), pp. 2011-2015.
    by A Brunet, LB Sweeney, JF Sturgill, KF Chua, PL Greer, Y Lin, H Tran, SE Ross, R Mostoslavsky, HY Cohen, LS Hu, HL Cheng, MP Jedrychowski, SP Gygi, DA Sinclair, FW Alt, ME Greenberg
  • High glucose downregulates endothelial progenitor cell number via SIRT1.
    Biochimica et biophysica acta, Vol. 1784, No. 6. (June 2008), pp. 936-945.
  • A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases
    Cardiovascular Drug Discovery, Vol. 3, No. 3. (2008), pp. 156-164.
    by Sivaram Pillarisetti
  • Insulin resistance (HOMA) in relation to plasma cortisol, IGF-I and IGFBP-3. A study in normal short-statured and GH-deficient children.
    Hormone research, Vol. 58, No. 5. (2002), pp. 229-232.
    by M Bleicher, J Högel, S Wudy, M Wabitsch, J Homoki, W Sorgo, E Heinze
  • Resveratrol inhibits insulin responses in a SirT1-independent pathway.
    The Biochemical journal, Vol. 397, No. 3. (1 August 2006), pp. 519-527.
    by J Zhang
  • Resveratrol May Influence Blood Sugar Management
    by VRP Staff
  • Resveratrol in Health and Disease
    (2005)
    by Bharat B Aggarwal, Shishir Shishodia
  • Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
    Biochem. J., Vol. 404 (2007), pp. 449-458.
    by Claire Chaussade, Gordon W Rewcastle, Jackie D Kendall, William A Denny, CHO Kitty, Line M Grønning, Mei L Chong, Sasha H Anagnostou, Shaun P Jackson, Nathalie Daniele, Peter R Shepherd
  • GGT mediates link between BMI and dyslipidemia in Type 2 diabetics
    (11 December 2008)
    by Helen Albert
  • Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs.
    The British journal of nutrition, Vol. 99, No. 6. (June 2008), pp. 1208-1216.
  • Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells
    Am J Physiol Endocrinol Metab, Vol. 293, No. 3. (1 September 2007), pp. E645-655.
    by Subbiah Pugazhenthi, Leonid Akhov, Gopalan Selvaraj, Maorong Wang, Jawed Alam
  • R-Lipoic Acid
  • Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases
    Molecular and Cellular Neuroscience, Vol. 36, No. 3. (November 2007), pp. 305-312.
  • Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro
    Journal of Pineal Research, Vol. 23, No. 3. (1997), pp. 156-163.
    by Elmar Peschke, Dorothee Peschke, Thomas Hammer, Valer Csernus
  • Antagonism of the Serotonin (5-HT)-2 Receptor and Insulin Sensitivity: Implications for Atypical Antipsychotics
    Psychosom Med, Vol. 67, No. 5. (1 September 2005), pp. 748-751.
    by Maria Gilles, Annette Wilke, Daniel Kopf, Annemarie Nonell, Hendrik Lehnert, Michael Deuschle
  • Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome : The Insulin Resistance Atherosclerosis Study (IRAS)
    Circulation, Vol. 102, No. 1. (4 July 2000), pp. 42-47.
    by Andreas Festa, Ralph D'Agostino, George Howard, Leena Mykkanen, Russell P Tracy, Steven M Haffner
  • Spices May Protect Against Consequences Of High Blood Sugar
    Medical News Today (6 August 2008)
  • Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome
    Am J Physiol Heart Circ Physiol, Vol. 295, No. 6. (1 December 2008), pp. H2388-2398.
    by Sadaf S Ahanchi, Vinit N Varu, Nick D Tsihlis, Janet Martinez, Charles G Pearce, Muneera R Kapadia, Qun Jiang, Joseph E Saavedra, Larry K Keefer, Joseph A Hrabie, Melina R Kibbe
  • Peroxisome proliferator-activated receptor-α modulates insulin gene transcription factors and inflammation in adipose tissues in mice
    Molecular and Cellular Biochemistry
    by Akadiri Yessoufou, Jean-Marc Atègbo, Eugène Attakpa, Aziz Hichami, Kabirou Moutairou, Karim Dramane, Naim Khan
  • A critical role for PPAR-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
    PNAS, Vol. 100, No. 3. (4 February 2003)
    by Brian N Finck, Xianlin Han, Michael Courtois, Franck Aimond, Jeanne M Nerbonne, Attila Kovacs, Richard W Gross, Daniel P Kelly
  • Effects of Topical Elk Velvet Antler on Cutaneous Wound Healing in Streptozotocin-Induced Diabetic Rats
    The Journal of Alternative and Complementary Medicine, Vol. 10, No. 5. (2004), pp. 835-840.
    by John Mikler, Christine Theoret, Jerry C High
  • Metabolic endotoxemia initiates obesity and insulin resistance.
    Diabetes, Vol. 56, No. 7. (July 2007), pp. 1761-1772.
    by PD Cani, J Amar, MA Iglesias, M Poggi, C Knauf, D Bastelica, AM Neyrinck, F Fava, KM Tuohy, C Chabo, A Waget, E Delmée, B Cousin, T Sulpice, B Chamontin, J Ferrières, JF Tanti, GR Gibson, L Casteilla, NM Delzenne, MC Alessi, R Burcelin
  • Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier.
    Endocrinology, Vol. 149, No. 4. (April 2008), pp. 1514-1523.
    by WA Banks, S Dohgu, JL Lynch, MA Fleegal-DeMotta, MA Erickson, R Nakaoke, TQ Vo
  • Blood Sugar and Insulin Levels - Key Factors in Longevity
    Vitamin Research Project (2008)
    by Kimberly Pryor
  • Long-Term Coffee Consumption Significantly Reduces Type 2 Diabetes Risk
    (January 2004)
  • Caffeine Increases Blood Sugar In People With Type 2 Diabetes
    Medical News Today, (28 January 2008)
  • Caffeine Increases Ambulatory Glucose and Postprandial Responses in Coffee Drinkers With Type 2 Diabetes
    Diabetes Care, Vol. 31, No. 2. (1 February 2008), pp. 221-222.
    by James D Lane, Mark N Feinglos, Richard S Surwit
  • Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Endocrinology, Vol. 141, No. 11. (2000), pp. 4021-4031.
    by RA Memon, LH Tecott, K Nonogaki, A Beigneux, AH Moser, C Grunfeld, KR Feingold
  • Chronic Ventromedial Hypothalamic Infusion of Norepinephrine and Serotonin Promotes Insulin Resistance and Glucose Intolerance
    Neuroendocrinology, Vol. 70 (1999), pp. 460-465.
    by Shuqin Luo, Jing Luo, Anthony H Cincotta
  • Beyond insulin resistance and syndrome X: the oxidative-dysoxygenative insulin dysfunction model—Part II - ODID
    Bnet.com, (October 2002)
    by Majid Ali
  • Note: You may cite this page as: http://www.citeulike.org/group/6182

    Result page: 1 2 3 4 Next RIS BibTeX RTF/PDF